Abstract
Myoclonus is characterized by rapid muscle jerks, while dystonia is defined as sustained twisting and repetitive movements, resulting in abnormal postures. In myoclonus dystonia (M-D), a predominantly myoclonic syndrome is combined with dystonic features. Linkage of autosomal dominantly inherited M-D is demonstrated to a locus on chromosome 7q, designated DYTll, followed by the recent identification of mutations in the 8-sarcoglycan gene (SGCE). However, SGCE clearly represents the major M-D gene. The function of its encoded protein, e-sarcoglycan, is largely unknown. It is a member of the sarcoglycan family, usually involved in muscular dystrophies, while M-D is a non degenerative disorder of the central nervous system. The drugs tested without any good effect on the involuntary movements are-amphetamine, heroin, carbamazepine, propranolol, chlorazepate, and haloperidol. Finally, neuro stimulation of the ventral intermediate thalamic nucleus is shown to be a safe and efficacious treatment in a patient with medically intractable and progressing M-D.
| Original language | English |
|---|---|
| Title of host publication | Genetics of Movement Disorders |
| Number of pages | 21 |
| Publisher | Elsevier Inc. |
| Publication date | 2003 |
| Pages | 451-471 |
| ISBN (Print) | 9780125666527 |
| DOIs | |
| Publication status | Published - 2003 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Myoclonus and Myoclonus-Dystonias'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver